Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Edoxaban Versus Standard of Care and Their Effects on Clinical Outcomes in Patients Having Undergone Transcatheter Aortic Valve Implantation (TAVI) - in Atrial Fibrillation

NCT02943785 is registered in ClinicalTrials.gov with Daiichi Sankyo as lead sponsor.

NCT NCT02943785
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02943785 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Edoxaban Versus Standard of Care and Their Effects on Clinical Outcomes in Patients Having Undergone Transcatheter Aortic Valve Implantation (TAVI) - in Atrial Fibrillation
Lead sponsor
Daiichi Sankyo
Phase
Phase 3
Overall status
Completed
Start date
March 21, 2017
Completion date
February 28, 2021
Enrollment
1,426 (actual)
Sites
230

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation